Guangdong Qianhui Biotechnology Co., Ltd.
乾晖生物
Guangdong Qianhui Biotechnology Co., Ltd.
Biotech/Healthcare
Qianhui Technology is developing China’s first contact-type hybrid human-cell bioartificial liver support system. The company was jointly established by Rongyi Venture Capital, Zhujiang Hospital of Southern Medical University, and the project’s core technical team.
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.